CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response.
Szlachta K, Kuscu C, Tufan T, Adair SJ, Shang S, Michaels AD, Mullen MG, Fischer NL, Yang J, Liu L, Trivedi P, Stelow EB, Stukenberg PT, Parsons JT, Bauer TW, Adli M.
Szlachta K, et al. Among authors: bauer tw.
Nat Commun. 2018 Oct 15;9(1):4275. doi: 10.1038/s41467-018-06676-2.
Nat Commun. 2018.
PMID: 30323222
Free PMC article.